Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.38 |
| ▸ | PLAUR | Q03405 | 4/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | PDE5A | O76074 | 1/20 | 0.35 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19397353 | 0.97 | KDM4E (0.43) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL19397577 | 0.96 | KDM4E (0.41) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL19397654 | 0.91 | KDM4E (0.44) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL19397644 | 0.90 | KDM4E (0.47) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL19397666 | 0.85 | KDM4E (0.45) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL17714777 | 0.84 | KDM4E (0.44) | KDM4EMAPTHPGDALDH1A1L3MBTL1 | |
| SCHEMBL19397465 | 0.84 | ESR2 (0.50) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL16805684 | 0.84 | KDM4E (0.46) | KDM4EMAPTHPGDALDH1A1L3MBTL1 | |
| SCHEMBL19397431 | 0.84 | MAPT (0.42) | KDM4EMAPTHPGDALDH1A1POLB | |
| SCHEMBL19397470 | 0.84 | MAPT (0.42) | KDM4EMAPTHPGDALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2020-03-03 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | C1S, AOC2, L1CAM | KDM4E 2356/4885MAPT 3242/4885HPGD 3527/4885 |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | L1CAM, C1S, F10 | KDM4E 2750/4885MAPT 3912/4885HPGD 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.